GLENMARK PHARMACEUTICALS, . USA H-1B Visa Sponsorship & Salary Data

The median H-1B salary at GLENMARK PHARMACEUTICALS, . USA is $118,000, based on 24 certified filings from FY 2021 to FY 2026. This is 2% lower than the national H-1B median salary of $120,000. Compensation at GLENMARK PHARMACEUTICALS, . USA reflects their market positioning, with entry-level roles starting around $105,309 and senior positions reaching $200,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at GLENMARK PHARMACEUTICALS, . USA range from $95,000 at the 10th percentile to $200,000 at the 90th percentile, showing a $105,000 spread across experience levels and roles. The 25th percentile is $105,309 and the 75th percentile is $139,616.

Yes, GLENMARK PHARMACEUTICALS, . USA actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 25 H-1B labor condition applications from FY 2021 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 24 certified applications and a 0% denial rate, GLENMARK PHARMACEUTICALS, . USA maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), GLENMARK PHARMACEUTICALS, . USA filed 1 H-1B applications, with 1 certified and 0 denied. Over 6 years of data, GLENMARK PHARMACEUTICALS, . USA has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

GLENMARK PHARMACEUTICALS, . USA's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 25 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating GLENMARK PHARMACEUTICALS, . USA as a potential H-1B sponsor.

This is an excellent approval rate, indicating GLENMARK PHARMACEUTICALS, . USA has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

GLENMARK PHARMACEUTICALS, . USA sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 24 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles GLENMARK PHARMACEUTICALS, . USA most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at GLENMARK PHARMACEUTICALS, . USA:

The most frequently sponsored role is Validation Specialist with 4 filings at a median salary of $107,000. This is followed by Senior Research Scientist (2 filings) and Validation Specialist, Sterile-Injection & Blow Fill Seal.

GLENMARK PHARMACEUTICALS, . USA's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where GLENMARK PHARMACEUTICALS, . USA sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top GLENMARK PHARMACEUTICALS, . USA H-1B locations:

The largest H-1B hub for GLENMARK PHARMACEUTICALS, . USA is Monroe, NC with 21 filings at a median salary of $111,662. The highest-paying location is Elmwood Park, NJ at $210,000 median. Salaries range from $111,662 to $210,000 across office locations.

GLENMARK PHARMACEUTICALS, . USA's median H-1B salary has increased by +34% from FY 2021 ($105,309) to FY 2026 ($141,589). Tracking salary trends over time reveals how GLENMARK PHARMACEUTICALS, . USA adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at GLENMARK PHARMACEUTICALS, . USA.

Year-by-year breakdown:

• FY 2022: $118,000 (4 certified)
• FY 2023: $107,000 (1 certified)
• FY 2024: $125,000 (4 certified)
• FY 2025: $192,571 (8 certified)
• FY 2026: $141,589 (1 certified)

This 34% growth reflects strong compensation adjustments at GLENMARK PHARMACEUTICALS, . USA, keeping pace with market demands for H-1B talent.

GLENMARK PHARMACEUTICALS, . USA primarily files H-1B applications at Wage Level III, accounting for 71% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making GLENMARK PHARMACEUTICALS, . USA's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 96% of positions at Level II or higher, GLENMARK PHARMACEUTICALS, . USA typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

GLENMARK PHARMACEUTICALS, . USA's median H-1B salary of $118,000 is 2% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating GLENMARK PHARMACEUTICALS, . USA's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare GLENMARK PHARMACEUTICALS, . USA's offerings with similar companies in your field for a more accurate assessment.

GLENMARK PHARMACEUTICALS, . USA's H-1B salaries are competitive with industry averages. The 24 total filings indicate active H-1B sponsorship.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. GLENMARK PHARMACEUTICALS, . USA's higher proportion of Level III-IV positions (83%) may benefit from wage-based lottery prioritization.

With 24 certified filings, GLENMARK PHARMACEUTICALS, . USA invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.